It was Nelson Mandela who said, “Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.” Introducing vaccines to developing countries has been one of the greatest public health feats of our century, with as much as a 70% reduction in the number of people dying from vaccine-preventable diseases achieved in the past two decades. 

This quiet revolution means that today a child born in Mombasa will enjoy similar access to life-saving vaccines as a child born in Munich. Levelling this playing field between the world’s richest and poorest countries has required bold actions and innovations: aggregating demand to leverage economies of scale; introducing “vaccine bonds” to provide upfront financing for large-scale investments; incentivising vaccine manufacturers to develop affordable products; and forging purposeful partnerships with public and private institutions, as well as civil society...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now